Highland Marketing Advisory Board Responds to the NHS Long Term Plan
The first meeting of Highland Marketing's newly expanded advisory board discussed the NHS Long Term Plan and what will be needed to make it a success. Structural change, leadership, investment, spending on the right systems at the right level, and empowerment emerged as key themes.
Read more ...
Merck Granted U.S. Patent for Novel Combination of Artificial Intelligence and Blockchain Technology
Merck, a leading science and technology company, today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO). The patent relates to the formation of 'crypto-objects', a novel security procedure linking Artificial Intelligence (AI) and blockchain technology.
Read more ...
Clinical Study Confirms Effectiveness of CardioSecur® in Pre-Clinical Deployment in Ambulances
The study "CardioSecur® in the preclinical setting - When time does matter" of the University of Heidelberg confirms the advantages of the mobile ECG in acute cases. This was demonstrated by applying CardioSecur during a period of more than 7 months in ambulances in the area of Heidelberg, Germany.
Read more ...
BIOTRONIK Announces First Enrollment in CRT-Next Study
BIOTRONIK has announced first enrollment in a multicenter study that aims to demonstrate that a two-lead cardiac resynchronization therapy (CRT) system with atrial sensing is at least as effective as a conventional three-lead system. BIOTRONIK's CRT-DX technology provides therapy through two ventricular leads and features a floating dipole for complete atrial diagnostics without an additional lead.
Read more ...
NHS Transformation Professionals Team Up to Help UK Hospitals with Improvement Ambitions
A network of NHS transformation professionals has launched to support NHS and private healthcare providers in improving the safety, effectiveness and experience of care. Called Transforming Healthcare Consultancy (THC), the team of individual specialists will provide health service improvement, change management and digital transformation services.
Read more ...
Merck and Tencent Announce Collaboration on Intelligent Digital Healthcare Services in China
Merck, a leading science and technology company, signed a strategic collaboration agreement with Tencent, a leading provider of Internet value added services. The collaboration will primarily focus on increasing public disease awareness and providing more accessible healthcare services via digital platforms in China, by leveraging the company's scientific leadership and expertise combined with Tencent's leading technology in the fields of internet and artificial intelligence.
Read more ...
Applications Now Open for Pioneering Digital Health Accelerator Programme
The Yorkshire & Humber AHSN (Academic Health Science Network), in partnership with mHabitat, announces that applications for the 2019 Propel@YH digital health accelerator programme are now open. Propel@YH has been launched to provide innovative organisations developing digital health solutions with access to a structured course of support and advice aimed at helping its business cohort to navigate the NHS, whilst enabling accelerated company growth and increased market presence.
Read more ...
The first meeting of Highland Marketing's newly expanded advisory board discussed the NHS Long Term Plan and what will be needed to make it a success. Structural change, leadership, investment, spending on the right systems at the right level, and empowerment emerged as key themes. 
Merck, a leading science and technology company, today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO). The patent relates to the formation of 'crypto-objects', a novel security procedure linking Artificial Intelligence (AI) and blockchain technology. 
The study "CardioSecur® in the preclinical setting - When time does matter" of the University of Heidelberg confirms the advantages of the mobile ECG in acute cases. This was demonstrated by applying CardioSecur during a period of more than 7 months in ambulances in the area of Heidelberg, Germany. 
BIOTRONIK has announced first enrollment in a multicenter study that aims to demonstrate that a two-lead cardiac resynchronization therapy (CRT) system with atrial sensing is at least as effective as a conventional three-lead system. BIOTRONIK's CRT-DX technology provides therapy through two ventricular leads and features a floating dipole for complete atrial diagnostics without an additional lead. 
A network of NHS transformation professionals has launched to support NHS and private healthcare providers in improving the safety, effectiveness and experience of care. Called Transforming Healthcare Consultancy (THC), the team of individual specialists will provide health service improvement, change management and digital transformation services.